{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:35:10Z","timestamp":1773117310715,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13019-016-0519-7","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T20:30:36Z","timestamp":1470256236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Daptomycin for the treatment of major gram-positive infections after cardiac surgery"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8420-171X","authenticated-orcid":false,"given":"A.","family":"Kornberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Luchting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. A.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Beiras-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"519_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1749-8090-8-132","volume":"8","author":"H Kuboba","year":"2013","unstructured":"Kuboba H, Miyata H, Motomura N, Ono M, Takamoto S, Harii K, Oura N, Hirabayashi S, Kyo S. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg. 2013;8:132.","journal-title":"J Cardiothorac Surg"},{"key":"519_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1053\/j.jvca.2009.02.007","volume":"23","author":"F Filsoufi","year":"2009","unstructured":"Filsoufi F, Castillo JG, Rahmanian PB, Broumand SR, Silvay G, Carpentier A, Adams DH. Epidemiology of deep sternal wound infection in cardiac surgery. J Cardiothorac Vasc Anesth. 2009;23:488\u201394.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jacc.2014.04.052","volume":"64","author":"AC Gelijns","year":"2014","unstructured":"Gelijns AC, Moskowitz AJ, Acker MA, Argenziano M, Geller NL, Puskas JD, Perrault LP, Smith PK, Kron IL, Michler RE, Miller MA, Gardner TJ, Ascheim DD, Ailawadi G, Lackner P, Goldsmith LA, Robichaud S, Miller RA, Rose EA, Ferguson Jr TB, Horvath KA, Moquete EG, Parides MK, Bagiella E, O\u2019Gara PT, Blackstone EH, Cardiothoracic Surgical Trials Network (CTSN). Management practices and major infections after cardiac surgery. J Am Coll Cardiol. 2014;64:372\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"519_CR4","doi-asserted-by":"publisher","first-page":"I358","DOI":"10.1161\/CIRCULATIONAHA.105.574954","volume":"112","author":"VG Fowler Jr","year":"2005","unstructured":"Fowler Jr VG, O\u2019Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 2005;112:I358\u201365.","journal-title":"Circulation"},{"key":"519_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ajic.2012.01.012","volume":"40","author":"LF Chen","year":"2012","unstructured":"Chen LF, Arduino JM, Sheng S, Muhlbaier LH, Kanafani ZA, Harris AD, Fraser TG, Allen K, Corey GR, Fowler Jr VG. Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type. Am J Infect Control. 2012;40:963\u20138.","journal-title":"Am J Infect Control"},{"key":"519_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1086\/502423","volume":"25","author":"M Sharma","year":"2004","unstructured":"Sharma M, Berriel-Cass D, Baran Jr J. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 43-month period. Infect Control Hosp Epidemiol. 2004;25:468\u201371.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"519_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jtcvs.2009.10.006","volume":"139","author":"E Matros","year":"2010","unstructured":"Matros E, Aranki SF, Bayer LR, McGurk S, Neuwalder J, Orgill DP. Reduction in incidence of deep sternal wound infections: random or real? J Thorac Cardiovasc Surg. 2010;139:680\u20135.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"519_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/CIRCOUTCOMES.113.000770","volume":"7","author":"T Shih","year":"2014","unstructured":"Shih T, Zhang M, Kommareddi M, Boeve TJ, Harrington SD, Holmes RJ, Roth G, Theurer PF, Prager RL, Likoski DS, for the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. Center-level variation in infection rates after coronary artery bypass grafting. Circ Cardiovasc Qual Outcomes. 2014;7:567\u201373.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"519_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/ejcts\/ezr239","volume":"41","author":"A Chaudhuri","year":"2012","unstructured":"Chaudhuri A, Shekar K, Coulter C. Post-operative deep sternal wound infections: making an early microbiological diagnosis. Eur J Cardiothorac Surg. 2012;41:1304\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"519_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1010-7940(02)00084-2","volume":"21","author":"B Gardlund","year":"2002","unstructured":"Gardlund B, Vaage J, Bitkover CY. Postoperative mediastinitis in cardiac surgery \u2013 microbiology and pathogenesis. Eur J Cardiothorac Surg. 2002;21:825\u201330.","journal-title":"Eur J Cardiothorac Surg"},{"key":"519_CR11","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.athoracsur.2006.05.097","volume":"82","author":"AM Eklund","year":"2006","unstructured":"Eklund AM, Lyytik\u00e4inen O, Klemets P, Huotari K, Anttila VJ, Werkkala KA, Valtonen M. Mediastinitis after more than 10,000 cardiac surgical procedures. Ann Thorac Surg. 2006;82:1784\u20139.","journal-title":"Ann Thorac Surg"},{"key":"519_CR12","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1161\/01.CIR.0000093201.57771.47","volume":"108","author":"LM Baddour","year":"2003","unstructured":"Baddour LM, Bettman MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108:2015\u201331.","journal-title":"Circulation"},{"key":"519_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/eurheartj\/ehs352","volume":"34","author":"E Nof","year":"2013","unstructured":"Nof E, Epstein LM. Complications of cardiac implants: handling device infections. Eur Heart J. 2013;34:229\u201336.","journal-title":"Eur Heart J"},{"key":"519_CR14","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.ajic.2006.05.220","volume":"34","author":"LB Rice","year":"2006","unstructured":"Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control. 2006;34:S11\u201319.","journal-title":"Am J Infect Control"},{"key":"519_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jinf.2007.05.180","volume":"55","author":"DA Enoch","year":"2007","unstructured":"Enoch DA, Bygott JM, Daly ML, Karas JA. Daptomycin. J Infect. 2007;55:205\u201313.","journal-title":"J Infect"},{"key":"519_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2165\/00003495-200262030-00002","volume":"62","author":"PK Linden","year":"2002","unstructured":"Linden PK. Treatment options for vancomycin-resistant enterococcal infections. Drugs. 2002;62:425\u201341.","journal-title":"Drugs"},{"key":"519_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.108.786913","volume":"119","author":"K Karkouti","year":"2009","unstructured":"Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, Stuart A, McCluskey SA, Rubens FD, Sawchuk C, Beatty WS. Acute kidney injury after cardiac surgery. Circulation. 2009;119:495\u2013502.","journal-title":"Circulation"},{"key":"519_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.00240605","volume":"1","author":"MH Rosner","year":"2006","unstructured":"Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19\u201332.","journal-title":"Clin J Am Soc Nephrol"},{"key":"519_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2044.2009.05889.x","volume":"64","author":"D Hauer","year":"2009","unstructured":"Hauer D, Kilger E, Kaufmann I, Kreth S, Beiras-Fernandez A, Briegel J, Schelling G, Schmidt M, Weis F. Risk and outcome analysis of renal replacement therapies in patients after cardiac surgery with pre-operatively normal renal function. Anaesthesia. 2009;64:615\u20139.","journal-title":"Anaesthesia"},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/jac\/dki106","volume":"55","author":"NP Wiederhold","year":"2005","unstructured":"Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother. 2005;55:792\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR21","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1128\/AAC.47.10.3145-3148.2003","volume":"47","author":"J Curtin","year":"2003","unstructured":"Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother. 2003;47:3145\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"519_CR22","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1097\/01.CCM.0000178288.70057.47","volume":"33","author":"S Blot","year":"2005","unstructured":"Blot S. MRSA pneumonia: better outcome through continuous infusion of vancomycin? Crit Care Med. 2005;33:2127\u20138.","journal-title":"Crit Care Med"},{"key":"519_CR23","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1086\/519471","volume":"45","author":"ST Micek","year":"2007","unstructured":"Micek ST. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2007;45:S184\u2013190.","journal-title":"Clin Infect Dis"},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1586\/14787210.5.2.177","volume":"5","author":"ZA Kanafani","year":"2007","unstructured":"Kanafani ZA, Corey GR. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of gram-positive infections. Expert Rev Anti Infect Ther. 2007;5:177\u201384.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"519_CR25","first-page":"95","volume":"3","author":"A Beiras-Fernandez","year":"2010","unstructured":"Beiras-Fernandez A, Vogt F, Sodian R, Weis F. Daptomycin: a novel lipopeptide antibiotic against gram-positive pathogens. Infect Drug Resist. 2010;3:95\u2013101.","journal-title":"Infect Drug Resist"},{"key":"519_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.diagmicrobio.2008.01.016","volume":"61","author":"M Castanheira","year":"2008","unstructured":"Castanheira M, Jones RN, Sader HS. Update of the in vitro activity of daptomycin tested against 6710 gram-positive cocci isolated in North America (2006). Diagn Microbiol Infect Dis. 2008;61:235\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jac\/46.4.523","volume":"46","author":"FP Tally","year":"2000","unstructured":"Tally FP, DeBruin MF. Development of daptomycin for gram-positive infections. J Antimicrob Chemother. 2000;46:523\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.diagmicrobio.2005.02.015","volume":"52","author":"PF Smith","year":"2005","unstructured":"Smith PF, Booker BM, Ogundele AB, Kelchin P. Comparative in vitro activities of daptomycin, linezolid, and quinupristin\/dalfopristin against Gram-positive bacterial isolates from a large cancer center. Diagn Microbiol Infect Dis. 2005;52:255\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"519_CR29","volume-title":"Summary of product characteristics","author":"Novartis Europharm Ltd","year":"2009","unstructured":"Novartis Europharm Ltd. Summary of product characteristics. 2009."},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/tcrm.2006.2.2.169","volume":"2","author":"DM Shoemaker","year":"2006","unstructured":"Shoemaker DM, Simou J, Roland WE. A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections. Ther Clin Risk Manag. 2006;2:169\u201374.","journal-title":"Ther Clin Risk Manag"},{"key":"519_CR31","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1185\/030079905X74961","volume":"21","author":"MS Finney","year":"2005","unstructured":"Finney MS, Crank CW, Segreti J. Use of daptomycin to treat drug-resistant gram-positive bone and joint infections. Curr Med Res Opin. 2005;21:1923\u20136.","journal-title":"Curr Med Res Opin"},{"key":"519_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1749-8090-7-81","volume":"7","author":"F Weis","year":"2012","unstructured":"Weis F, Heyn J, Hinske CL, Vogt F, Weis M, Kur F, Hagl C, Beiras-Fernandez A. Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery. J Cardiothorac Surg. 2012;7:81.","journal-title":"J Cardiothorac Surg"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/jac\/dkq528","volume":"66","author":"A Gonzalez-Ruiz","year":"2011","unstructured":"Gonzalez-Ruiz A, Beiras-Fernandez A, Lehmkuhl H, Seaton RA, Loeffler J, Chaves RL. Clinical experience with daptomycin in Europe: the first 2.5\u00a0years. J Antimicrob Chemother. 2011;66:912\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1749-8090-6-112","volume":"6","author":"AF Popov","year":"2011","unstructured":"Popov AF, Schmitto JD, Jebran AF, Bireta C, Friedrich M, Rajaruthnam D, Coskun KO, Braeuer A, Hinz J, Tirilomis T, Schoendube FA. Treatment of gram-positive deep sternal wound infections in cardiac surgery \u2013 experiences with daptomycin. J Cardiothorac Surg. 2011;6:112.","journal-title":"J Cardiothorac Surg"},{"key":"519_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1749-8090-8-21","volume":"8","author":"KR Ort","year":"2013","unstructured":"Ort KR, Jebran FA, Bireta C, Danner BC, Bougioukas I, Schoendube FA, Popov AF. Midterm results after treatment of gram-positive deep sternal wound infection with daptomycin for cardiac surgery patients. J Cardiothorac Surg. 2013;8:21.","journal-title":"J Cardiothorac Surg"},{"key":"519_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jcpt.12030","volume":"38","author":"RP Moenster","year":"2013","unstructured":"Moenster RP, Linneman TW, Call WB, Kay CL, McEvoy TA, Sanders JL. The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults. J Clin Pharm Ther. 2013;38:89\u201396.","journal-title":"J Clin Pharm Ther"},{"key":"519_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/MAJ.0b013e31821e1e6b","volume":"342","author":"J Larioza","year":"2011","unstructured":"Larioza J, Girard A, Brown RB. Clinical experience with daptomycin for outpatient parenteral antibiotic therapy. Am J Med Sci. 2011;342:486\u20138.","journal-title":"Am J Med Sci"},{"key":"519_CR38","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/jac\/dkt067","volume":"68","author":"RA Seaton","year":"2013","unstructured":"Seaton RA, Malizos KN, Viale P, Gargalianos-Kakolyris P, Sanantonio T, Petrelli E, Pathan R, Heep M, Chaves RL. Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE database. J Antimicrob Chemother. 2013;68:1642\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1742-1241.2008.01824.x","volume":"62","author":"WJ Martone","year":"2008","unstructured":"Martone WJ, Lindfield KC, Katz DE. Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry. Int J Clin Pract. 2008;62:1183\u20137.","journal-title":"Int J Clin Pract"},{"key":"519_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1179\/joc.2009.21.4.414","volume":"21","author":"JA Crompton","year":"2009","unstructured":"Crompton JA, North DS, McConnel SA, Lamp KC. Safety and efficacy of daptomycin in the treatment of osteomyelitis: results from the CORE Registry. J Chemother. 2009;21:414\u201320.","journal-title":"J Chemother"},{"key":"519_CR41","first-page":"161","volume":"5","author":"K Yabuno","year":"2013","unstructured":"Yabuno K, Seki M, Miyawaki K, Miwa Y, Tomono K. High-dose short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure. Clin Pharmacol. 2013;5:161\u20136.","journal-title":"Clin Pharmacol"},{"key":"519_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2334-13-66","volume":"13","author":"CC Lai","year":"2013","unstructured":"Lai CC, Sheng WH, Wang JT, Cheng A, Chuang YC, Chen YC, Chang SC. Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients. BMC Infect Dis. 2013;13:66.","journal-title":"BMC Infect Dis"},{"key":"519_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1592\/phco.31.6.527","volume":"31","author":"R Kullar","year":"2011","unstructured":"Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy. 2011;31:527\u201336.","journal-title":"Pharmacotherapy"},{"key":"519_CR44","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"519_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/jac\/dkm437","volume":"61","author":"T Lalani","year":"2008","unstructured":"Lalani T, Boucher HW, Cosgrove SE, Fowler VG, Kanafani ZA, Vigliani GA, Campion M, Abrutyn E, Levine DP, Price CS, Rehm SJ, Corey GR, Karchmer AW, S. aureus Endocarditis and Bacteraemia Study Group. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2008;61:177\u201382.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11908-014-0429-6","volume":"16","author":"JR Smith","year":"2014","unstructured":"Smith JR, Claeys KC, Barber KE, Rybak MJ. High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it. Curr Infect Dis Rep. 2014;16:429.","journal-title":"Curr Infect Dis Rep"},{"key":"519_CR47","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/jac\/dkt294","volume":"68","author":"R Kullar","year":"2013","unstructured":"Kullar R, Casapao AM, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chemother. 2013;68:2921\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR48","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.amjmed.2007.07.011","volume":"120","author":"DP Levine","year":"2007","unstructured":"Levine DP, Lamp KC. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med. 2007;120:S28\u201333.","journal-title":"Am J Med"},{"key":"519_CR49","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jac\/dks467","volume":"68","author":"PM Dohmen","year":"2013","unstructured":"Dohmen PM, Guleri A, Capone A, Utili R, Seaton A, Gonz\u00e1lez-Ramallo VJ, Pathan R, Heep M, Chaves RL. Daptomycin for the treatment of infective endocarditis: results from a European registry. J Antimicrob Chemother. 2013;68:936\u201342.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR50","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.hrtlng.2007.02.012","volume":"36","author":"BA Cunha","year":"2007","unstructured":"Cunha BA, Mickail N, Eisenstein L. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin. Heart Lung. 2007;36:456\u201361.","journal-title":"Heart Lung"},{"key":"519_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.hrtlng.2007.04.003","volume":"37","author":"BA Cunha","year":"2008","unstructured":"Cunha BA, Krol V, Kodali V. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job\u2019s syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin. Heart Lung. 2008;37:72\u20135.","journal-title":"Heart Lung"},{"key":"519_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/cid\/cir805","volume":"54","author":"E Durante-Mangoni","year":"2012","unstructured":"Durante-Mangoni E, Casillo R, Bernardo M, Caianiello C, Mattucci I, Pinto D, Agrusta F, Caprioli R, Albisinni R, Ragone E, Utili R. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis. Clin Infect Dis. 2012;54:347\u201354.","journal-title":"Clin Infect Dis"},{"key":"519_CR53","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1016\/j.hrtlng.2012.02.002","volume":"41","author":"C Tascini","year":"2012","unstructured":"Tascini C, Bongiorni MG, Di Cori A, Di Paoulo A, Polidori M, Tagliaferri E, Fondelli S, Soldati E, Ciullo I, Leonildi A, Danesi R, Coluccia G, Menichetti F. Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal. Heart Lung. 2012;41:E24\u201330.","journal-title":"Heart Lung"},{"key":"519_CR54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.hrtlng.2005.09.010","volume":"35","author":"BA Cunha","year":"2006","unstructured":"Cunha BA, Eisenstein LE, Hamid NS. Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: cure with prolonged\/high-dose daptomycin without toxicity. Heart Lung. 2006;35:207\u201311.","journal-title":"Heart Lung"},{"key":"519_CR55","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1016\/j.hlc.2014.06.009","volume":"23","author":"KR Santo","year":"2014","unstructured":"Santo KR, Franceschi V, Campos AC, Monteiro TS, Barbosa GI, Dantas A, Lamas CC. Pacemaker endocarditis caused by Propionibacterium acnes in an adult patient with Ebstein\u2019s anomaly: a report of a rare case. Heart Lung Circ. 2014;23:e222.","journal-title":"Heart Lung Circ"},{"key":"519_CR56","first-page":"428","volume":"22","author":"ML Fern\u00e1ndez Guerrero","year":"2013","unstructured":"Fern\u00e1ndez Guerrero ML, Robles I, Nogales Mdel C, Nuevo D. Corynebacterium striatum: an emerging nosocomial drug-resistant endocardial pathogen. J Heart Valve Dis. 2013;22:428\u201330.","journal-title":"J Heart Valve Dis"},{"key":"519_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2334-11-152","volume":"11","author":"LY Chen","year":"2011","unstructured":"Chen LY, Huang CH, Kuo SC, Hsiao CY, Lin ML, Wang FD, Fung CP. High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report. BMC Infect Dis. 2011;11:152.","journal-title":"BMC Infect Dis"},{"key":"519_CR58","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1128\/AAC.01728-08","volume":"53","author":"PS Stewart","year":"2009","unstructured":"Stewart PS, Davison WM, Steenbergen JN. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother. 2009;53:3505\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"519_CR59","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1128\/AAC.49.12.5046-5050.2005","volume":"49","author":"II Raad","year":"2005","unstructured":"Raad II, Hanna HA, Boktour M, Chaiban G, Hachem RY, Dvorak T, Lewis R, Murray BE. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene and decreased susceptibility to antibiotics in biofilm. Antimicrob Agents Chemother. 2005;49:5046\u201350.","journal-title":"Antimicrob Agents Chemother"},{"key":"519_CR60","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1128\/AAC.00350-06","volume":"51","author":"I Raad","year":"2007","unstructured":"Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 2007;51:1656\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"519_CR61","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.transproceed.2009.06.126","volume":"41","author":"A Beiras-Fernandez","year":"2009","unstructured":"Beiras-Fernandez A, Kur F, Kiefer S, Sodian R, Schmoeckel M, Weis M, Reichart B, Weis F. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin. Transplant Proc. 2009;41:2589\u201391.","journal-title":"Transplant Proc"},{"key":"519_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1749-8090-9-63","volume":"9","author":"V Walter","year":"2014","unstructured":"Walter V, Stock UA, Soriano-Romero M, Schnitzbauer A, Moritz A, Beiras-Fernandez A. Eradication of a chronic wound and driveline infection after redo-LVAD implantation. J Cardiothorac Surg. 2014;9:63.","journal-title":"J Cardiothorac Surg"},{"key":"519_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.athoracsur.2007.02.001","volume":"84","author":"F Weis","year":"2007","unstructured":"Weis F, Beiras-Fernandez A, Kaczmarek I, Sodian R, Vicol C, Reichart B, Weis M. Daptomycin for eradication of a systemic infection with a methicillin-resistant-Staphylococcus aureus in a biventricular assist device recipient. Ann Thorac Surg. 2007;84:269\u201370.","journal-title":"Ann Thorac Surg"},{"key":"519_CR64","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1086\/533441","volume":"46","author":"PE Pertel","year":"2008","unstructured":"Pertel PE, Bernardo P, Fogarty C, Matthews P, Northland R, Benvenuto M, Thorne GM, Luperchio SA, Arbeit RD, Alder J. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumnonia. Clin Infect Dis. 2008;46:1142\u201351.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"519_CR65","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1086\/430352","volume":"191","author":"JA Silverman","year":"2005","unstructured":"Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191(12):2149\u201352.","journal-title":"J Infect Dis"},{"key":"519_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1\u201345.","journal-title":"Clin Infect Dis"},{"key":"519_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler Jr VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, F\u00e4tkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, for the S. Aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653\u201365.","journal-title":"N Engl J Med"},{"key":"519_CR68","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1128\/AAC.00247-06","volume":"50","author":"M Benvenuto","year":"2006","unstructured":"Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50:3245\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"519_CR69","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1345\/aph.1K579","volume":"42","author":"G Abraham","year":"2008","unstructured":"Abraham G, Finkelberg D, Spooner LM. Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis. Ann Pharmacother. 2008;42:719\u201321.","journal-title":"Ann Pharmacother"},{"key":"519_CR70","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/jac\/dku277","volume":"69","author":"W He","year":"2014","unstructured":"He W, Zhang Y, Chen H, Zhao C, Wang H. Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials. J Antimicrob Chemother. 2014;69:3181\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"519_CR71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000192392","volume":"55","author":"SH Liang","year":"2009","unstructured":"Liang SH, Sheng WH, Huang YT, Wu FL, Chang CS. Pharmacokinetics and safety of multiple intravenous doses of daptomycin in a Taiwanese adult population. Chemotherapy. 2009;55:91\u20136.","journal-title":"Chemotherapy"},{"key":"519_CR72","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/cid\/cit023","volume":"56","author":"BM Knoll","year":"2013","unstructured":"Knoll BM, Spieler PJ, Kubiak DW, Marty FM. Neutropenia associated with prolonged daptomycin use. Clin Infect Dis. 2013;56:1353\u20134.","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-016-0519-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13019-016-0519-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-016-0519-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-016-0519-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T12:08:28Z","timestamp":1487592508000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-016-0519-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s13019-016-0519-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]},"article-number":"120"}}